| PERIOD ENDING | 30-Nov-08 | 30-Nov-07 | 30-Nov-06 | | Total Revenue | 44,417 | 39,703 | 40,842 | | Cost of Revenue | 4,888 | 4,308 | 4,241 | | | Gross Profit | 39,529 | 35,394 | 36,601 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 175 | 804 | 891 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 39,354 | 34,590 | 35,710 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (83,679) | (15,494) | (898) | | Earnings Before Interest And Taxes | 39,354 | 34,590 | 33,422 | | Interest Expense | 3,873 | 1,283 |
-
| | Income Before Tax | 35,481 | 33,307 | 33,422 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (48,198) | 17,813 | 34,812 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (48,198) | 17,813 | 34,812 | | Preferred Stock And Other Adjustments | (9,248) | (10,527) | (9,283) | | | Net Income Applicable To Common Shares | ($57,446) | $7,287 | $25,529 |
|
0.31% Nasdaq 
0.05%
Income Statement
